Celularity
CELU
55 hedge funds and large institutions have $184M invested in Celularity in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 5 closing their positions.
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
31% more funds holding
Funds holding: 42 → 55 (+13)
0.74% less ownership
Funds ownership: 7.12% → 6.38% (-0.74%)
11% less capital invested
Capital invested by funds: $207M → $184M (-$22.3M)
60% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 20
Top Buyers
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$7.21M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$5.68M |
| 3 |
JP Morgan Chase
New York
|
+$4.1M |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$3.64M |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
+$3.11M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
51
Weiss Asset Management
Boston,
Massachusetts
| $128K | +$126K | +1,217 | New |
|
52
Geode Capital Management
Boston,
Massachusetts
| $105K | +$104K | +1,000 | New |
|
|
PCM
53
Penserra Capital Management
Orinda,
California
| $17K | +$17.6K | +170 | New |
|
54
Millennium Management
New York
| $8.23K | +$61.5K | +594 | +0.8% |
|
55
UBS Group
Zurich,
Switzerland
| $1K | -$104 | -1 | -9% |
|
|
SRCM
56
Sage Rock Capital Management
New York
| – | -$5.1M | -50,000 | Closed |
|
|
NAM
57
Nexpoint Asset Management
Dallas,
Texas
| – | -$108K | -1,060 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$11K | -112 | Closed |
|
|
PAM
59
Panagora Asset Management
Boston,
Massachusetts
| – | -$1K | -14 | Closed |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -10 | Closed |
|
CELU Hedge Fund Activity: Q3 2020 in Review
55 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2020, worth a combined $184M — down 11% from $207M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CELU positions and 5 closed out — a net gain of 13 holders — while 8 added to existing stakes and 20 trimmed.
The largest buyer was Periscope Capital, adding an estimated $7.21M. The largest seller was W.R. Berkley Corp, cutting an estimated $16.1M.
- 55 institutional investors held Celularity (CELU) as of Q3 2020, up from 42 in Q2 2020.
- Funds reported $184M of Celularity stock for Q3 2020, down 11% quarter-over-quarter.
- 18 funds opened new Celularity positions in Q3 2020 and 5 closed out, a net change of +13 holders.
- The largest Celularity buyer in Q3 2020 was Periscope Capital, an estimated $7.21M added.
- The largest Celularity seller in Q3 2020 was W.R. Berkley Corp, an estimated $16.1M sold.
Based on aggregated 13F filings for Q3 2020.